Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-11-12Clinical Trial Update: Heterogeneity of Diabetes: Integrated Muli-Omics to Identify Physiologic Subphenotypes and Evaluate Targeted Prevention [Phase 4]
This Phase 4 clinical study from Stanford investigates the heterogeneity of diabetes using integrated multi-omics to identify physiologic su…
-
CLINICAL_TRIALS trial_result · 2024-11-12Clinical Trial Update: Effect of Gene Polymorphisms on GLP-1 Receptor Agonists Response in Patients With T2DM [NA]
A completed clinical trial update examining how gene polymorphisms affect patient response to GLP-1 receptor agonists in Type 2 Diabetes Mel…
-
CLINICAL_TRIALS research · 2024-11-12Clinical Trial Update: Effect of Flaxseed as a Treatment for Adults With Type 2 Diabetes Mellitus in Mexico [NA]
A clinical trial in Mexico is investigating the effect of flaxseed as a treatment for adults with Type 2 diabetes mellitus that is not well …
-
CLINICAL_TRIALS trial_result · 2024-11-12Clinical Trial Update: Acute Effects of Aerobic Exercise on Flow Mediated Slowing and Flow Mediated Dilation in Adults With and Without Type 2 Diabetes [NA]
This update reports results from a completed clinical trial examining the acute effects of aerobic exercise on vascular function in adults w…
-
CLINICAL_TRIALS withdrawal · 2024-11-12Clinical Trial Update: Feasibility and Acceptability of a Remote Glucose Monitoring Program for Pregnant Marshallese Women
The clinical trial evaluating the feasibility and acceptability of a remote glucose monitoring program for pregnant Marshallese women has be…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-11-12Clinical Trial Update: A Trial to Evaluate the Effect of C21 on Endothelial Dysfunction in Subjects With Type 2 Diabetes [Phase 1]
Phase 1 trial results for C21 in adults with type 2 diabetes assessed its effect on endothelial dysfunction; results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-11-12Clinical Trial Update: Black Barley Study - Barley to Support Food and Drink Innovation (RI-B7-3) [NA]
A University of Aberdeen trial evaluated black barley as a functional ingredient related to Type 2 Diabetes and has completed.
-
CLINICAL_TRIALS trial_result · 2024-11-12Clinical Trial Update: Digitally-Enabled Weight Management Program on T2DM
Clinical trial update announcing the completion of a study evaluating a digitally-enabled weight management program for individuals with Typ…
-
CLINICAL_TRIALS trial_result · 2024-11-08Clinical Trial Update: A Study to Evaluate Long-term Safety and Efficacy of ASP1941 in Diabetes Patients [Phase 3]
Phase 3 trial evaluating the long-term safety and efficacy of ASP1941 in Type 2 Diabetes Mellitus has completed.
-
CLINICAL_TRIALS trial_result · 2024-11-08Clinical Trial Update: Post-Marketing Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Ipragliflozin in Combination With GLP-1 Receptor Agonists in Japanese Patients With Type 2 Diabetes Mellitus (T2DM) [Phase 4]
Phase 4 post-marketing study evaluating the long-term safety, tolerability, and efficacy of ipragliflozin in combination with GLP-1 receptor…
-
CLINICAL_TRIALS trial_result · 2024-11-08Clinical Trial Update: A Study to Evaluate the Renal Protective Effect (Urine Albumin-to-Creatinine Ratio (UACR)), Efficacy and Safety of Ipragliflozin in Type 2 Diabetes Mellitus Patients With Albuminuria [Phase 4]
A Phase 4 study evaluating the renal protective effect of ipragliflozin in patients with Type 2 diabetes mellitus and albuminuria was termin…
-
CLINICAL_TRIALS trial_result · 2024-11-08Clinical Trial Update: A Study to Assess the Efficacy and Safety of Ipragliflozin in Combination With Insulin in Subjects With Type 2 Diabetes Mellitus [Phase 4]
Phase 4 clinical trial evaluating the efficacy and safety of ipragliflozin in combination with insulin for type 2 diabetes; the study status…
-
CLINICAL_TRIALS research · 2024-11-08Clinical Trial Update: Evaluating a Digital Intervention for Alleviating Diabetes-specific Emotional Distress in Adults Living With T2DM [NA]
The document reports an ongoing clinical trial evaluating a digital intervention to alleviate diabetes-specific emotional distress in adults…
-
CLINICAL_TRIALS trial_result · 2024-11-07Clinical Trial Update: Diabetes Homeless Medication Support [Phase 2]
Phase 2 clinical trial results for a medication-support program targeting adults with Type 2 diabetes experiencing housing instability; resu…
-
CLINICAL_TRIALS research · 2024-11-07Clinical Trial Update: Determining Circadian Metabolic and Behavioural Rhythms in Patients with and Without Type 2 Diabetes
A clinical trial from Steno Diabetes Center Copenhagen is studying circadian metabolic and behavioral rhythms in adults with and without Typ…
-
CLINICAL_TRIALS research · 2024-11-07Clinical Trial Update: The Effects of CGM and Connected Pen in T2DM Treated With Multiple Daily Insulin Injections [NA]
A study evaluating continuous glucose monitoring and a connected insulin pen in people with Type 2 diabetes mellitus on multiple daily insul…
-
CLINICAL_TRIALS research · 2024-11-06Clinical Trial Update: The Use of Statin in Diabetic Patients Not Known to Have Atherosclerotic Cardiovascular Disease
A clinical trial update on using statins in patients with type 2 diabetes mellitus who have no known atherosclerotic cardiovascular disease;…
-
EMA approval · 2024-11-06EMA Authorised: Byetta (exenatide) — AstraZeneca AB
The EMA authorised Byetta (exenatide) for the treatment of Type 2 diabetes mellitus; decision date: 05 November 2024.
-
CLINICAL_TRIALS trial_result · 2024-11-05Clinical Trial Update: Alberta Diabetes and Physical Activity Trial [Phase 2]
Clinical trial update for a Phase 2 study conducted by the University of Alberta evaluating physical activity in adults with Type 2 diabetes…
-
CLINICAL_TRIALS trial_result · 2024-11-05Clinical Trial Update: A Research Study to Look Into How Well Semaglutide Medicine Works at Different Doses in People With Type 2 Diabetes and Overweight [Phase 2]
A Phase 2 trial evaluated multiple doses of semaglutide in adults with type 2 diabetes mellitus and overweight. Results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-11-05Clinical Trial Update: A Clinical Trial of the Study Medicine (PF-07081532) in People With Diabetes and Kidney Dysfunction [Phase 1]
A Phase 1 trial of PF-07081532 in people with type 2 diabetes mellitus and chronic kidney disease was terminated; results have been posted.
-
CLINICAL_TRIALS research · 2024-11-05Clinical Trial Update: A Pragmatic Trial Comparing Empagliflozin and Dapagliflozin Through Cluster Randomization Embedded in the Electronic Health Record [Phase 4]
This is a Phase 4 pragmatic trial comparing empagliflozin and dapagliflozin, embedded in the electronic health record using cluster randomiz…
-
CLINICAL_TRIALS trial_result · 2024-11-05Clinical Trial Update: Study of Subcutaneously Administered ENT-03 for the Treatment of Obesity and Diabetes [Phase 1]
Phase 1 study of ENT-03, a subcutaneously administered therapy from Metabolics Pharma, for obesity and Type 2 Diabetes Mellitus is currently…
-
CLINICAL_TRIALS trial_result · 2024-11-05Clinical Trial Update: Home Based Resistance Training For Type 2 Diabetes [Phase 1]
Phase 1 clinical trial from the University of Alberta evaluating home-based resistance training for Type 2 diabetes; the study status is com…
-
CLINICAL_TRIALS research · 2024-11-05Clinical Trial Update: The Impact of Type 2 Diabetes Mellitus on Cardiovascular Events in Saudi Arabia Now and Future
A clinical trial sponsored by King Faisal Specialist Hospital & Research Center studies how Type 2 diabetes mellitus affects cardiovascular …